Media coverage
25
Media coverage
Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet PR Newswire Country/Territory United States Date 15/12/21 Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Street Insider Country/Territory United States Date 15/12/21 URL https://www.streetinsider.com/PRNewswire/Ivantis+Announces+First+Patient+Enrolled+in+Pivotal+Clinical+Trial+Evaluating+the+Hydrus+Microstent+in+Standalone+MIGS+for+Mild+to+Moderate+Glaucoma/19354239.html Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet BioSpace Country/Territory United States Date 15/12/21 URL https://www.biospace.com/article/releases/ivantis-announces-first-patient-enrolled-in-pivotal-clinical-trial-evaluating-the-hydrus-microstent-in-standalone-migs-for-mild-to-moderate-glaucoma/?s=106 Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Yahoo! Finance Country/Territory United States Date 15/12/21 URL https://finance.yahoo.com/news/ivantis-announces-first-patient-enrolled-140000445.html Persons Nathan Radcliffe Title 1st Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Medical Device News Magazine Country/Territory United States Date 15/12/21 URL https://infomeddnews.com/1st-patient-enrolled-in-pivotal-clinical-trial-evaluating-the-hydrus-microstent/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WFMZ-TV Online Country/Territory United States Date 15/12/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/ivantis-announces-first-patient-enrolled-in-pivotal-clinical-trial-evaluating-the-hydrus-microstent-in-standalone/article_2080ee90-d142-5cf8-a168-76acf1b4a5e2.html Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet My Sun Coast Country/Territory United States Date 15/12/21 URL www.mysuncoast.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet NBC12 Online Country/Territory United States Date 15/12/21 URL www.nbc12.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WALB 10 Country/Territory Georgia Date 15/12/21 URL www.walb.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Wave 3 Country/Territory United States Date 15/12/21 URL www.wave3.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Fox 19 Country/Territory United States Date 15/12/21 URL www.fox19.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet KOLO TV Reno Country/Territory United States Date 15/12/21 URL https://www.kolotv.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WRDW Country/Territory United States Date 15/12/21 URL https://www.wrdw.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WIBW Country/Territory United States Date 15/12/21 URL https://www.wibw.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet KWTX Country/Territory United States Date 15/12/21 URL https://www.kwtx.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WBKO Country/Territory United States Date 15/12/21 URL https://www.wbko.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Kgns.tv Country/Territory United States Date 15/12/21 URL https://www.kgns.tv/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet KPLC TV Country/Territory United States Date 15/12/21 URL www.kplctv.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet KCBD Country/Territory United States Date 15/12/21 URL www.kcbd.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Hawaii News Now Country/Territory United States Date 15/12/21 URL www.hawaiinewsnow.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WOWT Country/Territory United States Date 15/12/21 URL https://www.wowt.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Webcenter 11 Country/Territory United States Date 15/12/21 URL https://www.webcenterfairbanks.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet WTOK-TV Country/Territory United States Date 15/12/21 URL https://www.wtok.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma Media name/outlet Upper Michigans Source Country/Territory United States Date 15/12/21 URL https://www.uppermichiganssource.com/prnewswire/2021/12/15/ivantis-announces-first-patient-enrolled-pivotal-clinical-trial-evaluating-hydrus-microstent-standalone-migs-mild-moderate-glaucoma/ Persons Nathan Radcliffe Title Ivantis Begins Hydrus Microstent for Standalone Glaucoma MIGS Trial Media name/outlet Medical Product Outsourcing Country/Territory United States Date 15/12/21 URL https://www.mpo-mag.com/contents/view_breaking-news/2021-12-15/ivantis-begins-hydrus-microstent-for-standalone-glaucoma-migs-trial/ Persons Nathan Radcliffe